Maria Diab - Concepedia

Author

Maria Diab

Emory University ORCID

Also Known As

Diab, Maria, M Diab, M. Diab, Marena D. Diab, Maria Diab, Maria M Diab

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Emory University Wayne State University Winship Cancer Institute

About

Maria Diab is an author at Emory University specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	939
2	Cell Biology	1	1	37
3	Immunology	1	1	11
4	Pathology	1	1	11
5	Pharmacology	1	1	37

Maria Diab

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, The Lancet UrologySurgical OncologyGastrointestinal OncologyMedicineBiliary Cancer	2023	891
Gastric Cancer Heterogeneity and Clinical Outcomes Rachel Sexton, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Technology in Cancer Research & Treatment	2020	49
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth Husain Yar Khan, Gabriel Mpilla, Rachel Sexton, Cancers Calcium Release-activated CalciumTumor BiologyPancreatic CancerMedicinePdac Pdx Model	2020	37
Research productivity in Syria: Quantitative and qualitative analysis of current status Maria Diab, Rokana Taftaf, Mohammad Arabi Avicenna Journal of Medicine	2011	36
Predictive and Prognostic Effects of Primary Tumor Size on Colorectal Cancer Survival Olatunji B. Alese, Wei Zhou, Renjian Jiang, Frontiers in Oncology	2021	35
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer Mehmet Akce, Batoul Farran, Jeffrey M. Switchenko, Journal for ImmunoTherapy of Cancer	2023	34
High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer Amr Mohamed, Renjian Jiang, Philip A. Philip, Frontiers in Oncology	2021	15
Phase Ib/II trial of siltuximab and spartalizumab in patients in metastatic pancreatic cancer. Mehmet Akce, Walid L. Shaib, Maria Diab, Journal of Clinical Oncology ImmunologyPathologyImmunologic MechanismMetastatic Pancreatic CancerImmunotherapy	2022	11

Page 1